NEW YORK (GenomeWeb) – Two shareholders have filed a class action lawsuit against Illumina and two of its top officials, claiming that the defendants made materially false and misleading statements regarding the firm's business, operations, and prospects between the announcement of Illumina's second quarter and preliminary third quarter financial results that led to an inflated share price.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.